Literature DB >> 11856910

What is new in endothelium-derived hyperpolarizing factors?

William B Campbell1, Kathryn M Gauthier.   

Abstract

The chemical identification and functional characterization of endothelium-derived hyperpolarizing factors varies depending on vascular size, vascular bed and species. Three major candidates are the epoxyeicosatrienoic acids, cytochrome P450 metabolites of arachidonic acid, potassium ion and hydrogen peroxide. Additionally, electrical coupling through myoendothelial gap junctions serves to conduct electrical changes from the endothelium to the smooth muscle and may mediate or propagate hyperpolarization. Endothelium-derived hyperpolarizing factors are important mediators of vascular relaxation most specifically in resistance sized arteries where they regulate tissue blood flow. The release of the factors is modulated by a number of influences including agonist stimulation, shear stress, estrogen and disease. This article reviews the latest studies concerning the characterization of endothelium-derived hyperpolarizing factors, the mechanisms of factor release and alterations of the factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11856910     DOI: 10.1097/00041552-200203000-00008

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  12 in total

Review 1.  The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function.

Authors:  Kyra E Pyke; Michael E Tschakovsky
Journal:  J Physiol       Date:  2005-07-28       Impact factor: 5.182

2.  Spatial separation of endothelial small- and intermediate-conductance calcium-activated potassium channels (K(Ca)) and connexins: possible relationship to vasodilator function?

Authors:  Shaun L Sandow; Craig B Neylon; Mao X Chen; Christopher J Garland
Journal:  J Anat       Date:  2006-11       Impact factor: 2.610

3.  Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.

Authors:  Brandon T Larsen; Hiroto Miura; Ossama A Hatoum; William B Campbell; Bruce D Hammock; Darryl C Zeldin; John R Falck; David D Gutterman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-28       Impact factor: 4.733

4.  H2O2 is the transferrable factor mediating flow-induced dilation in human coronary arterioles.

Authors:  Yanping Liu; Aaron H Bubolz; Suelhem Mendoza; David X Zhang; David D Gutterman
Journal:  Circ Res       Date:  2011-01-13       Impact factor: 17.367

5.  Epoxyeicosatrienoic acids are released to mediate shear stress-dependent hyperpolarization of arteriolar smooth muscle.

Authors:  An Huang; Dong Sun; Azita Jacobson; Mairead A Carroll; John R Falck; Gabor Kaley
Journal:  Circ Res       Date:  2005-01-06       Impact factor: 17.367

6.  Endothelium-dependent hyperpolarization-related relaxations diminish with age in murine saphenous arteries of both sexes.

Authors:  Ramesh Chennupati; Wouter H Lamers; S Eleonore Koehler; Jo G R De Mey
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

7.  Developmental changes in myoendothelial gap junction mediated vasodilator activity in the rat saphenous artery.

Authors:  Shaun L Sandow; Kenichi Goto; Nicole M Rummery; Caryl E Hill
Journal:  J Physiol       Date:  2004-02-06       Impact factor: 5.182

8.  Insulin resistance and endothelial dysfunction: Are epoxyeicosatrienoic acids the link?

Authors:  Sally Mustafa; Vijay Sharma; John H McNeill
Journal:  Exp Clin Cardiol       Date:  2009

9.  A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury.

Authors:  Dominik N Muller; Juergen Theuer; Erdenechimeg Shagdarsuren; Eva Kaergel; Horst Honeck; Joon-Keun Park; Marija Markovic; Eduardo Barbosa-Sicard; Ralf Dechend; Maren Wellner; Torsten Kirsch; Anette Fiebeler; Michael Rothe; Hermann Haller; Friedrich C Luft; Wolf-Hagen Schunck
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

10.  PPARα activation can help prevent and treat non-small cell lung cancer.

Authors:  Nataliya Skrypnyk; Xiwu Chen; Wen Hu; Yan Su; Stacey Mont; Shilin Yang; Mahesha Gangadhariah; Shouzuo Wei; John R Falck; Jawahar Lal Jat; Roy Zent; Jorge H Capdevila; Ambra Pozzi
Journal:  Cancer Res       Date:  2013-12-03       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.